Abstract:Bone Morphogenetic Proteins (BMPs) and other members of TGFβ superfamily regulate cell growth and differentiation. Abrogation of cellular responses to BMP/TGFβ is associated with human diseases such as cancer, cardiovascular, autoimmune and skeletal diseases. One of the most critical events in activation of BMP signal transduction pathway is the phosphorylation of transcription factor Smad1/5/8 (collective term for Smad1, Smad5 and Smad8) by BMP receptors. While phosphorylated Smad1/5/8 directly activate the BMP-induced gene transcription in the nucleus, protein phosphatases are anticipated to dephosphorylate phospho-Smad1/5/8 and consequently terminate BMP signaling. The identity of the long sought-after phosphatase has been one of the major unanswered questions in BMP/TGFβ biology. Objective: (1) To characterize how PPM1H physically interacts with and functionally dephosphorylate BMP-specific Smads, and (2) to investigate the functions of PPM1H in BMP-induced gene expression and osteoblast differentiation. Methods: We first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen for Smad phosphatases. BMP-induced Smad phosphorylation was analyzed using immunological methods such as immunoprecipitation, western blotting and immunofluorescence. Effects of PPM1H overexpression and knockdown on the level of Smad phosphorylation were determined by anti-phospho-Smad1 Western blotting. Real-time PCR, transcriptional analyses of BMP target genes and alkaline phosphatase assays were carried out to determine the functions of PPM1H in regulating BMP responses and osteoblast differentiation. Results: To identify the Smad phosphatases, we first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen. By using combined methods of functional genomics and biochemistry, we discovered that PPM1H represents a novel cytoplasm-localized Smad1/5/8-specific phosphatase. The effects of PPM1H on controlling the level of phosphorylated Smad1/5/8 (P-Smad1/5/8) were analyzed by immunological methods, e.g. immunofluorescence and western blotting, using a phospho-specific antibody against P-Smad1/5/8. PPM1H clearly dephosphorylated P-Smad1/5/8 in vivo and in vitro. In vitro binding, immunoprecipitation, and bimolecular fluorescence complementation assays demonstrated that PPM1H and Smad1 directly interact with each other in the cytoplasm. Consequently, ectopic expression of PPM1H in cells abolished BMP-induced gene expression as measured by real-time PCR and transcriptional reporter assays, and loss of PPM1H activity (site mutagenesis) or expression (RNA interference) greatly enhanced BMP signaling and osteoblast differentiation. Conclusion: PPM1H acts as a gatekeeper to prevent excessive BMP signal transduction through dephosphorylation and subsequent nuclear exclusion of Smad1/5/8. Our results not only gain insights into the important role of BMP signaling in human growth and development, but also are pertinent towards novel therapeutic approaches for the prevention and treatment of human diseases.

Novel Phosphatase PPM1H Controls BMP Signaling and Osteoblast Differentiation

Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H

Protein Serine/Threonine Phosphatase Ppm1a Dephosphorylates Smad1 in the Bone Morphogenetic Protein Signaling Pathway

Protein Phosphatase-1 Modulates the Function of Pax-6, a Transcription Factor Controlling Brain and Eye Development

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

PPM1A Functions As a Smad Phosphatase to Terminate TGFβ Signaling

Regulation of TGF-beta signalling by protein phosphatases.

C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation Via Smad Dephosphorylation*

Small C-terminal Domain Phosphatases Dephosphorylate the Regulatory Linker Regions of Smad2 and Smad3 to Enhance Transforming Growth Factor-β Signaling

Editorial NotePPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling

PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3.

PROTEIN PHOSPHATASE PPM1A INHIBITION ATTENUATES OSTEOARTHRITIS VIA REGULATION OF TGF-Β/SMAD2 SIGNALLING IN CHONDROCYTES

Termination of TGF-β Superfamily Signaling Through SMAD Dephosphorylation—A Functional Genomic View

Coupled Actions of PPM1A and RanBP3 Terminate TGFβ/SMAD Tumor Suppressor Functions

Nuclear Export of Smads by RanBP3L Regulates Bone Morphogenetic Protein Signaling and Mesenchymal Stem Cell Differentiation.

Protein phosphatase PPM1A inhibition attenuates osteoarthritis via regulating TGF-β/Smad2 signaling in chondrocytes

Bone Morphogenetic Protein-Smad Pathway As Drug Targets for Osteoporosis and Cancer Therapy

Promoting Bone Morphogenetic Protein Signaling Through Negative Regulation of Inhibitory Smads

Arginine Methylation of R81 in Smad6 Confines BMP-induced Smad1 Signaling

Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling

The protein phosphatase PPM1A dephosphorylates and activates YAP to govern mammalian intestinal and liver regeneration